Alcatraz AI Named as Axis Communications Axis Technology Integration Partner About the Partnership Companies will jointly market AI-powered facial authentication access control solutions to remove friction and make areas more secure. Alcatraz AI, a global leader in autonomous access control solutions, today announced a partnership with Axis Communications to provide Alcatraz AI’s flagship facial authentication…

Breaking News: Mega Matrix Corp. Announces Joint Venture with Bit Digital, Inc. Exciting Partnership Unveiled In a surprising turn of events, Mega Matrix Corp. has revealed its latest venture with Bit Digital, Inc. The partnership, spearheaded by Mega Matrix’s Singapore subsidiary Saving Digital Pte. Ltd., is set to revolutionize the tech industry as we know…

The Impact of Muinmos’ Partnership with DL Consulting on Regtech Industry Partnership Overview Regtech firm Muinmos recently announced its partnership with Cyprus-based fintech services consultancy, DL Consulting, for sales and implementation support. This partnership is expected to help Muinmos strengthen its presence in Cyprus and expand its reach internationally. Muinmos Taps DL Consulting’s Services The…

Specialized Segment leader and transportation industry veteran, Scott Hoppe, to become EVP and COO effective June 1, 2023 ADDISON, Texas, March 03, 2023 (GLOBE NEWSWIRE) — Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), a premier North American transportation solutions specialist dedicated to servicing challenging industrial end-markets, today announced that Executive Vice President (“EVP”) and…

Hepion Pharmaceuticals Receives European Patent for Rencofilstat Patent Covers 38 European Countries Rencofilstat’s Exclusivity May Extend into 2048 EDISON, N.J., March 02, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”),…

Checkpoint Therapeutics Announces FDA Filing Acceptance of Biologics License Application for Cosibelimab in Metastatic Understanding the Prescription Drug User Fee Act (“PDUFA”) Goal Date On January 3, 2024, the Prescription Drug User Fee Act (“PDUFA”) goal date for Cosibelimab in Metastatic will mark a significant milestone for Checkpoint Therapeutics, Inc. The FDA has indicated that…

Option Care Health Announces Pricing of Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell…

ROSEN, A TOP RANKED LAW FIRM, Encourages Inspirato Incorporated Investors to Secure Counsel Before Important Deadline in Securities Cla… New York, March 01, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inspirato Incorporated (NASDAQ: ISPO) between May 11, 2022 and December 15, 2022,…